Cargando…
Zinc transporters in Alzheimer’s disease
Alzheimer’s disease (AD) is the most devastating neurodegenerative disorder. Due to the increase in population and longevity, incidence will triple by the middle of the twenty-first century. So far, no treatment has prevented or reversed the disease. More than 20 years of multidisciplinary studies h...
Autores principales: | Xu, Yingshuo, Xiao, Guiran, Liu, Li, Lang, Minglin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6902570/ https://www.ncbi.nlm.nih.gov/pubmed/31818314 http://dx.doi.org/10.1186/s13041-019-0528-2 |
Ejemplares similares
-
Genetic Inhibition of Solute-Linked Carrier 39 Family Transporter 1 Ameliorates Aβ Pathology in a Drosophila Model of Alzheimer's Disease
por: Lang, Minglin, et al.
Publicado: (2012) -
Fear-of-intimacy-mediated zinc transport is required for Drosophila fat body endoreplication
por: Ji, Xiaowen, et al.
Publicado: (2023) -
Iron Homeostasis Disorder and Alzheimer’s Disease
por: Peng, Yu, et al.
Publicado: (2021) -
New insight into protein glycosylation in the development of Alzheimer’s disease
por: Zhao, Jingwei, et al.
Publicado: (2023) -
Copper Toxicity Links to Pathogenesis of Alzheimer’s Disease and Therapeutics Approaches
por: Ejaz, Hafza Wajeeha, et al.
Publicado: (2020)